We investigated the interaction between low density lipoproteins (LDL) and cultured Mahlavu hepatoma cells, which are a novel model of human hepatocytes. When Mahlavu cells were incubated with
125I-LDL at 4°C,
125I-LDL bound to the cells with high affinity, showing saturation kinetics (K
d=2×10
-8M, B
max=170ng LDL protein/mg cell protein).
At 37°C,
125I-LDL bound to Mahlavu cells was subsequently internalized and degraded. When incubated with 20-fold concentrations of cold VLDL, LDL and HDL, the degradation of
125I-LDL was inhibited by 56%, 87% and 25%, respectively, indicating that these binding sites were most specific for LDL.
The degradation of
125I-LDL was inhibited by 100μM chloroquine and 10mg/ml diethylaminoethoxyhexestrol (DH), both of which are strong inhibitors of lysosomal hydrolase, suggesting the LDL degradation site was located in the lysosome.
The rate of cholesterol synthesis was inhibited, while the rate of cholesterol esterification was increased by adding LDL to the culture medium in these cells. However, chloroquine reversed both the inhibition of cholesterol synthesis and the enhancement of cholesterol esterification by LDL.
These results suggest that Mahlavu cells have an LDL-receptor pathway which should be identical to those in other cells established by Goldstein and Brown. Mahlavu cells, a new human hepatoma cell line, are thought to be useful in investigating cholesterol metabolism in the liver.
View full abstract